1. Antibacterial activity of Myrciaria dubia (Camu camu) against Streptococcus mutans and Streptococcus sanguinis
   Rosella Camere-Colarossi et al, 2016, Asian Pacific Journal of Tropical Biomedicine CrossRef
2. U13 → C13 mutation in the variable region of the NA gene 3′UTR of H9N2 influenza virus influences the replication and transcription of NA and enhances virus infectivity
   Xi Li et al, 2019, Virus Genes CrossRef
3. Influenza-associated bacterial pneumonia; managing and controlling infection on two fronts
   Aaron Campigotto et al, 2015, Expert Review of Anti-infective Therapy CrossRef
4. Modulating cholesterol-rich lipid rafts to disrupt influenza A virus infection
   Yu-Jyun Li et al, 2022, Frontiers in Immunology CrossRef
5. Statin Treatment and Mortality: Propensity Score-Matched Analyses of 2007–2008 and 2009–2010 Laboratory-Confirmed Influenza Hospitalizations
   Matthew R. Laidler et al, 2015, Open Forum Infectious Diseases CrossRef
6. Dietary Cholesterol Causes Inflammatory Imbalance and Exacerbates Morbidity in Mice Infected with Influenza A Virus
   Allison Y. Louie et al, 2022, The Journal of Immunology CrossRef
7. Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing
   Punya Shrivastava-Ranjan et al, 2018, mBio CrossRef
8. Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target
   K. G. Arun et al, 2021, Journal of Biomolecular Structure and Dynamics CrossRef
9. Fluvastatin delays propagation of viral infection in isolated rat FDB myofibers but does not affect exocytic membrane trafficking
   Mika Nevalainen et al, 2015, Cell Biology International CrossRef
10. Rapid proteasomal elimination of 3-hydroxy-3-methylglutaryl-CoA reductase by interferon-γ in primary macrophages requires endogenous 25-hydroxycholesterol synthesis
    Hongjin Lu et al, 2015, Steroids CrossRef
11. Type I Interferon Counteracts Antiviral Effects of Statins in the Context of Gammaherpesvirus Infection
    Philip T. Lange et al, 2016, Journal of Virology CrossRef
12. Role of Lipid Rafts in Pathogen-Host Interaction - A Mini Review
    Rakesh Kulkarni et al, 2022, Frontiers in Immunology CrossRef
13. AMFR promotes innate immunity activation and proteasomal degradation of HMGCR in response to influenza virus infection in A549 cells
    Devendra Nath Tewari et al, 2023, Virology CrossRef
14. Fighting the flu: a brief review on anti-influenza agents
    Sambuddha Chakraborty et al, 2023, Biotechnology and Genetic Engineering Reviews CrossRef
15. Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase increases the expression of interferon-responsive genes
    Xin Yang et al, 2014, Clinical and Experimental Pharmacology and Physiology CrossRef
16. Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia
    Christopher Henry et al, 2018, Baylor University Medical Center Proceedings CrossRef
17. Antiviral drug discovery: broad-spectrum drugs from nature
    J. P. Martinez et al, 2015, Natural Product Reports CrossRef
18. Effect of atovastatin treatment on porcine circovirus 2 infection in BALB/c mice
    Xin Yang et al, 2015, Clinical and Experimental Pharmacology and Physiology CrossRef
19. 14-Deoxy-11,12-didehydroandrographolide attenuates excessive inflammatory responses and protects mice lethally challenged with highly pathogenic A(H5N1) influenza viruses
    Wentao Cai et al, 2016, Antiviral Research CrossRef
20. Anti-flavivirus Properties of Lipid-Lowering Drugs
    Carlos Noe Farfan-Morales et al, 2021, Frontiers in Physiology CrossRef
21. Statin Use and Risks of Influenza-Related Outcomes Among Older Adults Receiving Standard-Dose or High-Dose Influenza Vaccines Through Medicare During 2010–2015
    Hector S Izurieta et al, 2018, Clinical Infectious Diseases CrossRef
22. Antiviral activity of maca (Lepidium meyenii) against human influenza virus
    Juana del Valle Mendoza et al, 2014, Asian Pacific Journal of Tropical Medicine CrossRef
23. Current landscape and future prospects of antiviral drugs derived from microbial products
    Naoki Takizawa et al, 2018, The Journal of Antibiotics CrossRef
24. Antiviral Potential of Natural Resources against Influenza Virus Infections
    Johanna Eichberg et al, 2022, Viruses CrossRef
25. Interferon-inducer antivirals: Potential candidates to combat COVID-19
    Ashkan Bagheri et al, 2021, International Immunopharmacology CrossRef